thdbh120
Peptideexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 19, 2023 (NCT06744868)
Timeline
Indications
Mechanism of action
GLP1R agonist
GIPR agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07036601 | Phase 2 | Jan 6, 2025 | Tonghua Dongbao Pharmaceutical Co.,Ltd |
| NCT06951945 | Phase 1 | Jul 18, 2024 | Tonghua Dongbao Pharmaceutical Co.,Ltd |
| NCT07020949 | Phase 1 | Jun 13, 2024 | Tonghua Dongbao Pharmaceutical Co.,Ltd |
| NCT06744868 | Phase 1 | Dec 19, 2023 | Tonghua Dongbao Pharmaceutical Co.,Ltd |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Tonghua Dongbao Pharmaceutical Co.,Ltd | For profit | 4 | 4 | 2 | 2023 |
1 organizations
Page 1 / 1